結(jié)核病總論英文-文檔資料

1、2021/4/61我國結(jié)核病的疫情狀況 who 93年宣布“全球結(jié)核病緊急狀態(tài)”，98年又重申遏制結(jié)核病的行動刻不容緩。 全球現(xiàn)有結(jié)核病人2000萬，其中95在發(fā)展中國家，每年還會新發(fā)生800-1000萬肺結(jié)核病，其中75的病人年齡在1550歲。如不控制，今后10年還將有9000萬人發(fā)病。 中國是全球22個結(jié)核病高負(fù)擔(dān)國家之一，結(jié)核病人數(shù)位居世界第二位，僅次于印度. 據(jù)調(diào)查全國三分之一的人口已感染了結(jié)核菌；受感染人數(shù)超過4億,受結(jié)核感染人群中有10的人發(fā)生結(jié)核病2021/4/62tuberculosis factor of tuberculosis incidence rising ： hiv

2、 spread. tb strain occur drug resistance . fluid population increasing. management tb patient not perfect、prevention and cure not efficiency. poverty、population increasing.2021/4/63etiology mycobacterium 、 acid fastness、g+、aerobe。 growth torpidity , culture need 4-6 weeks. typing : human type 、 bovi

3、ne type 、 bird type、mouse type 、 main human type。 way of infection：respiration tract、digestive track、skin or placenta.2021/4/64epidemiology 1 infection sources：open pulmonary tuberculosis 2 route of transmission: by respiration way or digestion tract. 3 susceptible population2021/4/65epidemiology th

4、e factors lead children ill with tb contact tb amounts and toxicity. power of resistance . hereditary factor .2021/4/66pathogenesybacterial number、toxicity、immunization condition cell-mediated immune reaction:macrophage swallow tbantigen presentation th and macrophageil12cd+4th1-if-to promote mononu

5、clear cell; to gather、activation、proliferation and differentiationto produce alexin and oxidase 、 digestive enzymeto kill tb2021/4/67pathogenesy if-reinforcement cd+8 、nk cells activity to phagocytosis tb. meanwhile to lead histoclasia delayed allergy : t cell media，macrophage to be effector cell，to

6、 kill reinfection tb and cause cheesy necrosis or hole formation after infection tb : primary disease（5%），secondary disease （5%）, not to fall ill all live(90%)2021/4/68 diagnose objective to discover focal 。 definite disease character、size whether or not deliver bacterium。2021/4/69diagnose 1 history

7、 tb toxic symptom to contact tb patient bcg vaccination acute infection:measles，pertussis supersensitivity erythema nodosum、exanthematous conjunctivitis。2021/4/610diagnose 2 ：ot test agent：1/2000 or 1/10000 ppd dose：0.1ml（ot 5u）（or 1u）。 position：left forearm palmaris below 1/3 infuse intracutaneous

8、form 6-10mm hillock。 4872hr observation reaction。2021/4/611diagnosis reaction 5mm(-) 5mm(+) 10-19mm(+) 20mm(+) super reaction :induration、vesic 、 local ulceration (+)。2021/4/612diagnosis significance positive reaction after bcg vaccination older children positive reaction indicate to be ever infecte

9、d with tb before。 infant never bcg vaccination indicate new infection recent。 strong positive reaction indicate there is activeness tb.。 from（-）to（+）、from 10mm ,or increase 6mm by activeness tb.。2021/4/613diagnosis negative reaction never infection tb first infect tb during 4-8 weeks false negative

10、reaction，immune function to be pressed down。 wrong with test or ppd ineffective2021/4/614diagnosis bcg vaccination and natural infection positive reaction condition2021/4/615diagnosis3 ： laboratory examination（1）find tb specimen：sputum、gastric juice、c.s.f、serous cavity liquid. method：smear、 fluoresc

11、ent staining、 bactec system：culture for 2 weeks，test mycobacteria metabolism production，to distinguish tb and atypical .mycobacteria. l tubercle bacterium：mutation tb，form、construction、acid-fast staining different from common tb。easy passing placenta，therapeutic inefficacy。2021/4/616diagnosis（2）immu

12、nology and molecular biology test elisa（酶聯(lián)免疫吸附試驗） eliep（酶聯(lián)免疫電泳技術(shù)） dna探針 pcr （聚合酶鏈?zhǔn)椒磻?yīng)） 線條dna探針雜交試驗 esr (血沉)。2021/4/617diagnosis4 ： chest x-ray to definite focus of infection position 、extent、category、activity condition。 to evaluate and follow up therapeutic efficacy 。 ct more clear to find the focus、

13、 extent and spread condition。5：bronchofiberscopy check：to definite endotracheal membrane tb and tuberculosis of trachebronchial lymph nodes。6：lymph node puncture smear or lymphaden biopsy to diagnosis。2021/4/618tuberculotherapy general treatment nutrition、to take a rest。 avoiding to contact infectio

14、n disease 。 primarily tb treatment in out-patient clinic and regularity return visit 。 report epidemic situation。2021/4/619tuberculotherapy treatmen target to kill bacillus tuberculosis in focus to prevent disseminate。 therapeutic principle early treatment reasonable dosage combine medicine regulari

15、ty take drug to insist on whole course segmenting treatment.2021/4/620tuberculotherapy anti-tuberculosis drugs whole germicide：in acid and alkali，exterior and interior of cell can kill germ。(inh rfp) half germicide：in acid or alkali environment kill cell interior or exterior tb，sm /pza bacteriostati

16、c：emb（ethambutol) eth(ethionamide)2021/4/621tuberculotherapy new antituberculosis to anti drug resistant rifamate(contain inh 150mg rfp300mg) rifater(inh,rfp pza) old drug derivant：rifapentine new chemicals：dipasic，to delay resistant inh drug standard treatment： refer to asymptomatic primarily pulmo

17、nary tuberculosis usage：inh+rfpemb course of treatment 912 month.2021/4/622化療方案 two stage therapy refer to：activeness primarily pulmonary tb: acute miliary tuberculosis;brain tb; intensification therapy：（purpose） combination 34 germicide drugs longer 34mo、shorter 2mo。 continue treatment stage combin

18、ation two drugs to keep therapeutic effect for 1218mo.(longer rang)or 4mo. (short-rang) 。2021/4/623化療方案 short-range therapy who important strategy to cure tuberculosis mechanism of action is fast kill organism inner cell or out cell。 to sputum bacterium(-)，recovery fast ，recurrence less。 2hrz/4hr、2s

19、hrz/4hr、2ehrz/4hr2021/4/624antituberculosis drugsmedicine dose adverse reaction inh 1020 多發(fā)性神經(jīng)炎，肝損害rfp 1015 可逆性肝損害，消化道癥狀。尿紅色。pza 20-30 肝損害，高尿酸血癥。sm 1520 聽神經(jīng)損害,腎損害。emb 1520 球后視神經(jīng)炎。 2021/4/625tuberculosis prevention to control source of infection：smear(+) patient pervasion bcg vaccination：to have an i

20、noculation age is neonate. contraindicationcellular immunity deficiencyacute infectious disease convalescence stageregion eczema or general skin diseaseot（+）2021/4/626tuberculosis preventiondrug prevention indication: 1 close to contact open pulmonary tuberculosis in family 2 lower 3 years infant ha

21、ve not innoculation bcg; but ot（+） 3 ot from（-）to （+）recently 4 ot(+) with toxic symptom 5 ot（+）and recently ill with measles or pertussis 6 ot（+）need long-term to take corticosteroids or immunodepressant2021/4/627tuberculosis prevention approach 1 : inh 10mg/kg course of treatment 69mo. approach 2 : inh+rfp(10mg/kg) course 3 mo.2021/4/628原發(fā)性肺結(jié)核（primary pulmonary tuberculosis)發(fā)綜合癥（primary complex)原發(fā)病灶+局部病變淋巴結(jié)+淋巴管 支氣管淋巴結(jié)結(jié)核(胸腔內(nèi)腫大淋巴結(jié)結(jié)核)2021/4/629primary pulmonary tuberculosis本病變：滲出（炎癥細(xì)胞單核